nhs.predict - Breast Cancer Survival and Therapy Benefits
Calculate Overall Survival or Recurrence-Free Survival for
breast cancer patients, using 'NHS Predict'. The time interval
for the estimation can be set up to 15 years, with default at
10. Incremental therapy benefits are estimated for hormone
therapy, chemotherapy, trastuzumab, and bisphosphonates. An
additional function, suited for SCAN audits, features a more
user-friendly version of the code, with fewer inputs, but
necessitates the correct standardised inputs. This work is not
affiliated with the development of 'NHS Predict' and its
underlying statistical model. Details on 'NHS Predict' can be
found at: <doi:10.1186/bcr2464>. The web version of 'NHS
Predict': <https://breast.predict.nhs.uk/>. A small dataset of
50 fictional patient observations is provided for the purpose
of running examples with the main two functions, and an
additional dataset is provided for running example with the
dedicated SCAN function.